Vanguard Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $74.7M | Buy |
|
|||||
|
2021
Q2 | $135M | Buy |
|
|||||
|
2021
Q1 | $91.2M | Buy |
|
|||||
|
2020
Q4 | $73.9M | Buy |
|
|||||
|
2020
Q3 | $58.3M | Sell |
|
|||||
|
2020
Q2 | $84.8M | Buy |
|
|||||
|
2020
Q1 | $54.2M | Buy |
|
|||||
|
2019
Q4 | $62.4M | Buy |
|
|||||
|
2019
Q3 | $36.7M | Buy |
|
|||||
|
2019
Q2 | $36.8M | Buy |
|
|||||
|
2019
Q1 | $33.7M | Sell |
|
|||||
|
2018
Q4 | $25M | Buy |
|
|||||
|
2018
Q3 | $30.3M | Buy |
|
|||||
|
2018
Q2 | $17.3M | Buy |
|
|||||
|
2018
Q1 | $11.8M | Buy |
|
|||||
|
2017
Q4 | $5.32M | Buy |
|
|||||
|
2017
Q3 | $2.51M | Buy |
|
|||||
|
2017
Q2 | $1.08M | Buy |
|
|||||
|
2017
Q1 | $1.11M | Buy |
|
|||||
|
2016
Q4 | $935K | Sell |
|
|||||
|
2016
Q3 | $2.87M | Sell |
|
|||||
|
2016
Q2 | $1.6M | Sell |
|
|||||
|
2016
Q1 | $2.94M | Buy |
|
|||||
|
2015
Q4 | $6.19M | Buy |
|
|||||
|
2015
Q3 | $3.98M | Buy |
|
|||||
|
2015
Q2 | $5.95M | Buy |
|
|||||
|
2015
Q1 | $7.18M | Buy |
|
|||||
|
2014
Q4 | $3.92M | Buy |
|
|||||
|
2014
Q3 | $2.49M | Buy |
|
|||||
|
2014
Q2 | $2.67M | Buy |
|
|||||
|
2014
Q1 | $1.91M | Buy |
|